Nebulisation Chemotherapy for Lung Cancer
Author Information
Author(s): T. Tatsumura, S. Koyama, M. Tsujimoto, M. Kitagawa, S. Kagamimori
Primary Institution: Toyama Medical and Pharmaceutical University, School of Medicine
Hypothesis
Can nebulisation chemotherapy effectively deliver 5-FU to lung cancer tissues?
Conclusion
Nebulisation chemotherapy shows high efficacy in delivering 5-FU to lung cancer tissues with minimal side effects.
Supporting Evidence
- 5-FU levels were significantly higher in tumor tissues compared to normal lung tissues.
- 60% of patients showed a satisfactory anti-tumor response.
- 5-FU was not detected in blood samples during surgery.
Takeaway
This study found that a special way of giving cancer medicine through a mist can help treat lung cancer without hurting other parts of the body.
Methodology
The study involved administering 5-FU via nebulisation to both mongrel dogs and lung cancer patients, followed by tissue and serum analysis.
Limitations
The study had a small sample size and was limited to specific patient demographics.
Participant Demographics
19 lung cancer patients, 9 males and 1 female, aged 54 to 76 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website